Two-thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression

COMPASS Pathways has announced the findings from a survey of Sermo physician members that showed two thirds (66%) of doctors surveyed believe psilocybin therapy has potential therapeutic benefit for patients with treatment-resistant depression (TRD).